We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
  • SKIP TO CONTENT
  • SKIP NAVIGATION
  • Drug News
    • Trending
    • Commercial Operations
    • GMPs
    • FDA Enforcement Actions
    • Inspections and Audits
    • Postmarket Safety
    • Quality
    • Regulatory Affairs
    • Research and Development
    • Submissions and Approvals
    • FDAnews Drug Weekly
    • FDAnews
  • Device News
    • Trending
    • Commercial Operations
    • FDA Enforcement Actions
    • Inspections and Audits
    • Postmarket Safety
    • Quality
    • Regulatory Affairs
    • Research and Development
    • Submissions and Approvals
    • FDAnews Device Weekly
    • FDAnews
  • Books
    • FDAnews Books Library
    • Drug Books
    • Device Books
  • Training/Events
    • Webinar Training Pass
    • Events
  • Resources
    • Form 483s Database
    • FDA Approved Drugs
    • eCFR and Guidances
    • White Papers
  • CenterWatch
  • About Us
    • The Company
    • FDAnews Editorial Board
    • Contact Us
  • Advertising
  • Sign In
  • Create Account
  • Sign Out
  • My Account
Home » Store » Webinar Recordings » EU-MDR: Are You Ready? Part I – Webinar Recording/Transcript

Other Options

Webinar Recording & Transcript Bundle - Feb. 20, 2020

$287.00

Webinar Recording & Transcript Bundle - Feb. 20, 2020

$258.00

Webinar Recording & Transcript Bundle - Feb. 20, 2020

$244.00

Webinar Recording & Transcript Bundle - Feb. 20, 2020

$230.00

Webinar Recording & Transcript Bundle - Feb. 20, 2020

$215.00
James Pink

EU-MDR: Are You Ready? Part I – Webinar Recording/Transcript

$287.00
Webinar Recordings

Product Details

EU-MDR: Are You Ready? An Exclusive Three-Part FDAnews Webinar Series
Part I: The Real Role of the Person Responsible for Regulatory Readiness & Compliance

With the new European Union medical devices and in-vitro diagnostic medical device regulations going into effect in May 2020 and 2022, the role of the Person Responsible for Regulatory Compliance (PRRC) will ensure that there is adequate supervision and control of medical devices placed in the market.

But most manufacturers and regulators are currently only concentrating upon the specific experiences and qualifications necessary for a PRRC. The duties, responsibilities, authority and organizational design necessary to ensure a PRRC can supervise and control need to be carefully considered within the context of the organization.

Does your organization have the structure and processes in place to support the PRRC and ensure compliance?

Join us for an informative webinar on Feb. 20 to get a better sense of what the PRRC does to supervise and control the change management process as well as the release of product onto the market. This webinar is the first in an exclusive three-part FDAnews webinar series on EU-MDR readiness.

During the presentation, you’ll:

  • Find out why a PRRC is required in the first place and what is the PRRC duties and responsibilities
  • Determine whether the PRRC is over or under qualified or unable to fulfil their duties due to tasks overload
  • Get a sense of the relationship between the PRRC and the strategy set for regulatory compliance
  • Discover how the processes of a medical device manufacturer and other economic operators should be planned in order to fulfil the requirements for a PRRC
  • Critically evaluate whether your corporate structure is ready to ensure supervision and control of products to achieve EU regulatory compliance
  • Familiarize yourself with the importance of organizational design to ensure the various roles participating in compliance are understood and coordinated

Prepare for the new PPRC requirement and get ready for the upcoming EU-MDR deadlines with the first webinar in this exclusive three-part series. Join us by registering today for Part I or save 25% by registering for the complete three-part series.

The series also includes:

  • Part II: Tips for Assessing Your Readiness Prior to Notified Body Review
    Recorded on Friday, April 10, 2020. Purchase as a Webinar Recording/Transcript.
  • Part III: After May 2020, Ensuring Your Post-Market Surveillance Readiness via a Risk Management Framework
    Thursday, April 23, 2020, 1:30 p.m. - 3:00 p.m. EDT

Meet Your Presenter:

James Pink, Vice President, NSF Health Sciences Medical Devices, Europe
James Pink has more than 20 years’ experience in the medical device industry, including 10 years as a health care technology expert and Lead Auditor for a leading European Notified body. He has managed development and quality assurance programs for orthopedic, cardiovascular, wound, and combination products; and presented to the EU competent authorities and expert working groups relating to classification decisions, clinical study design, scientific and technical briefings. A major focus in recent years has been preparing for the advent of the EU Medical Device Regulation.

Who Will Benefit

  • Medical device / technology companies
  • In-Vitro diagnostic device companies
  • Quality manager
  • Regulatory manager
  • Operations manager
  • Design manager
  • Technical manager
  • Clinical manager
  • Authorized representative in Europe
  • Drug Products
    • Quality
    • Regulatory Affairs
    • GMPs
    • Inspections and Audits
    • Postmarket Safety
    • Submissions and Approvals
    • Research and Development
    • Commercial Operations
  • Device Products
    • Quality
    • Regulatory Affairs
    • QSR
    • Inspections and Audits
    • Postmarket Safety
    • Submissions and Approvals
    • Research and Development
    • Commercial Operations
  • Clinical Products
    • Trial Design
    • Data Integrity
    • GCP
    • Inspections and Audits
    • Transparency
  • Privacy Policy
  • Do Not Sell or Share My Data
Footer Logo

300 N. Washington St., Suite 200, Falls Church, VA 22046, USA

Phone 703.538.7600 – Toll free 888.838.5578

Copyright © 2023. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing